Cryoport, Inc.

NasdaqCM CYRX

Cryoport, Inc. EBT Margin for the Trailing 12 Months (TTM) ending September 30, 2024: -70.13%

Cryoport, Inc. EBT Margin is -70.13% for the Trailing 12 Months (TTM) ending September 30, 2024, a -280.55% change year over year. EBT Ratio (Earnings Before Tax Ratio) is the fraction of earnings before taxes to total revenue, indicating the company's profitability before the impact of tax expenses.

Cryoport, Inc. EBT Margin for the Trailing 12 Months (TTM) ending September 30, 2023 was -18.43%, a 85.07% change year over year.
Cryoport, Inc. EBT Margin for the Trailing 12 Months (TTM) ending September 30, 2022 was -123.46%, a -980.62% change year over year.
Cryoport, Inc. EBT Margin for the Trailing 12 Months (TTM) ending September 30, 2021 was -11.42%, a 79.45% change year over year.
Cryoport, Inc. EBT Margin for the Trailing 12 Months (TTM) ending September 30, 2020 was -55.60%, a 13.90% change year over year.

Key data

Date	EBT Margin	Net Income Margin	EBITDA Margin	EBIT Margin

NasdaqCM: CYRX

Cryoport, Inc.

CEO	Mr. Jerrell W. Shelton
IPO Date	Aug. 22, 2005
Location	United States
Headquarters	112 Westwood Place
Employees	1,100
Sector	Industrials
Industries Warehousing Biotechnology Container Shipping Containers & Packaging Frozen Foods Meat Non-Alcoholic Beverages Vaccines

Description

Cryoport, Inc., a life sciences services company, provides temperature-controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking and monitoring, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, which is used to ensure that the stability of shipped biologic commodities is maintained throughout the shipping cycle. It also provides information dashboards and validation documentation for shipments through data collected by the SmartPak Condition Monitoring System; and vacuum insulated aluminum dewars and cryogenic freezers systems. In addition, the company offers biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; transportation of frozen biological specimens to and from customer locations; and management of incoming and outgoing biological specimens, as well as provides logistics support and management; and short-term logistics and engineering consulting services. It serves biopharma/pharma, animal health, and human reproductive medicine markets. The company was founded in 1999 and is headquartered in Brentwood, Tennessee.

Key trends

Past 5 years